Napolitano, Daniele
Cilluffo, Silvia
Marini, Alessia
Lusignani, Maura
Funding for this research was provided by:
European Crohn's and Colitis Organisation (ID 9C67A07D-92CD-49AA-AA43-22266255E23B)
Article History
Received: 5 August 2025
Accepted: 5 December 2025
First Online: 12 December 2025
Declarations
:
: This study received approval from the Territorial Ethics Committee Lazio 3, under protocol number N. 0023486/23, approved on August 2, 2023. The study was also registered on ClinicalTrials.gov (NCT06015789, registered on September 4, 2023). The research was conducted in accordance with general ethical standards, adhering to the principles outlined in the Declaration of Helsinki [ ]. Participants were provided with both written and verbal information regarding the study’s objectives, emphasizing its voluntary nature. They were informed of their right to withdraw from the study at any point without any consequences. Anonymity was ensured through the use of aggregated data analysis. Data collection commenced only after obtaining informed consent from each participant.
: Not applicable.
: The authors declare no competing interests.